Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yufei Liu
Institutions:
Jiangsu Cancer Hospital,
Nanjing Medical University
Observed institutions:
Jiangsu Cancer Hospital,
Nanjing Medical University
ORCID:
0000-0001-6138-6638
Observed ORCID:
0000-0001-6138-6638
OpenAlex ID:
A5029118450
Clinical Efficacy of Pyrotinib Combined with Capecitabine in the Second-Line or Above Treatment for HER-2 Positive Advanced Breast Cancer and Its Association with Cell-Free DNA
2022
·
Yajun Miao
, Juan Chen
, et al.
·
Journal of Oncology
·
4
PDF
BGB-A317-212: A multicenter, open-label, phase II study to evaluate the efficacy and safety of tislelizumab in combination with lenvatinib in patients with selected solid tumors.
2024
·
Yufei Liu
, Zhisong He
, et al.
·
Journal of Clinical Oncology
·
1
CLIC6 and ANLN: novel exosome-related prognostic markers and therapeutic targets in lung adenocarcinoma
2026
·
Yajun Miao
, Tao Li
, et al.
·
Frontiers in Immunology
PDF
Show more works
View as search
Works count:
3
Citation count:
5
H-index:
1
I10-index:
Year
Topic
Type